Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies.

Mohammad ZamaniShaghayegh Alizadeh-TabariMohammad Hassan MuradSiddharth SinghAshwin N Ananthakrishnan Reza Malekzadeh Nicholas J Talley

Published in: Alimentary pharmacology & therapeutics (2024)

The risk of lymphoma is only modestly increased in patients with IBD, with Crohn's disease having a slightly higher risk than ulcerative colitis. In IBD, there appears to be no difference between the risks of Hodgkin's and non-Hodgkin's lymphoma.

Keyphrases

ulcerative colitis
diffuse large b cell lymphoma
patients with inflammatory bowel disease
systematic review
hodgkin lymphoma
meta analyses
randomized controlled trial
human health
climate change
case control